Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.320
-0.150 (-4.32%)
At close: Jun 1, 2026, 4:00 PM EDT
3.423
+0.103 (3.10%)
After-hours: Jun 1, 2026, 4:53 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.15 million as of June 1, 2026. Its market cap has decreased by -35.86% in one year.
Market Cap
2.15M
Enterprise Value
-9.22M
1-Year Change
-35.86%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.15M, a decrease of -97.89%. That is a compound annual growth rate of -41.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.25M | 18.15% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 3.43M |
| GRI Bio | 2.98M |
| Calidi Biotherapeutics | 2.85M |
| Oragenics | 2.73M |
| Ensysce Biosciences | 2.61M |
| Valion Bio | 2.40M |
| Bone Biologics | 2.37M |
| Jaguar Health | 2.14M |